Skip to main content
Log in

Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Barta SK, Gong JZ, Porcu P. Brentuximab vedotin in the treatment of CD30+ PTCL. Blood 2019; 134: 2339–45.

    Article  PubMed  Google Scholar 

  2. Ragmanauskaite L, Brahmbhatt M, Cheeley JT. Drug rash with eosinophilia and systemic symptoms related to Brentuximab vedotin: a report of 2 cases. JAAD Case Rep 2020; 6: 1119–22.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mansoor N, McKenna L, Molloy O, et al. Emergence of lymphomatoid papulosis during treatment with Brentuximab vedotin. Int J Dermatol 2020; 59: e332–4.

    Article  PubMed  Google Scholar 

  4. van de Donk NW, Dhimolea E. Brentuximab vedotin. MAbs 2012; 4: 458–65.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Canal-Garcia E, Alamon-Reig F, Combalia A. Diffuse alopecia areata induced by Brentuximab vedotin therapy for advanced stage mycosis fungoides. Dermatol Ther 2022; 35: e15427.

    Article  CAS  PubMed  Google Scholar 

  6. Seong GH, Yun DK, Shon U, et al. A case of pityriasis lichenoides et varioliformis acuta-like eruption developed after pembrolizumab treatment for invasive thymoma. Ann Dermatol 2021; 33: 94–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shin Iinuma.

Ethics declarations

Conflicts of interest: none.

Additional information

Financial support: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iinuma, S., Kobayashi, T. & Ishida-Yamamoto, A. Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma. Eur J Dermatol 33, 316–317 (2023). https://doi.org/10.1684/ejd.2023.4494

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2023.4494

Navigation